Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
Tevogen Bio logo

Tevogen Bio

Recent Finacing

Grant

Recent Raise

$8M

Tevogen Bio is a clinical-stage biotech developing cell and gene therapies using a PredicTcell platform and Tevogen.AI to design off-the-shelf, HLA-matched donor-derived T-cell therapeutics (e.g., TVGN-489 COVID-19 trial).

Founded 2020
New Jersey, United States
501-1K
Publicly Traded
tevogen.com
PitchBook

Highlights

Focus Areas

Biopharma
Biotechnology
Health Care
Life Science
Medical
Oncology
Pharmaceutical
Product Research
Therapeutics

Recent Investors

K
H

Financials

$5B

Valuation as of 03/15/2022

$8M

Total Raised

2

Funding rounds

2

Investors


Team

Upgrade to view the team

See the team members at Tevogen Bio.